Abstract. To understand the relationship between transforming growth factor α (TGFα) and mammary gland involution, changes in the growth of normal and preneoplastic mammary glands, the expression of TGFα and epidermal growth factor receptor (EGFR) mRNAs in the mammary gland, and serum prolactin (PRL) level were examined in 3-month-old virgin SHN mice 4 to 108 days after ovariectomy (OVX). The formation of normal end-buds and preneoplastic hyperplastic alveolar nodules was significantly reduced after 9 days of OVX, associated with the decreased serum PRL level. Both TGFα and EGFR mRNA expression in the mammary glands declined 18 days after OVX. Thereafter, TGFα mRNA tended to increase, while EGFR mRNA continued to decrease. These observations suggest that the decline of both estrogen and PRL play major roles in the mammary gland involution after OVX, and that the decline of EGFR, through which TGFα manifests its effects, play a secondary role in this process. Key words: EGFR, Mammary gland, Mouse, Ovariectomy, TGFα.
TGFα and EGFR mRNAs in the mammary gland and the growth of normal and preneoplastic mammary gland in OVX mice. We also examined the changes in serum prolactin (PRL) levels in these mice, since PRL is one of the key hormones necessary for mammary gland growth and secretion of PRL is largely controlled by ovarian estrogen [15] .
Materials and Methods

Animals and treatments
Animals used were virgin SHN/Mei mice maintained in our laboratory by strict brother × sister mating [16] . At 3 months of age, they were divided into two groups; the first group underwent a sham operation and served as the control. The ransforming growth factor α (TGFα) is a polypeptide which has been suggested to play T an important role in the growth of normal and abnormal mammary tissues [1] [2] [3] [4] [5] [6] . TGFα relates structurally to epidermal growth factor (EGF) [7] and binds to epidermal growth factor receptor (EGFR) on the cell surface [8] . Since the expression of TGFα is reported to be modulated by estrogen [9] [10] [11] [12] [13] [14] and it is well established that ovariectomy (OVX) induces a marked involution of the mammary gland, we addressed the question whether the change in the TGFα level has a role in the mammary gland involution after OVX.
In this study, we examined the expression of second group was bilaterally ovariectomized (OVX) via a dorsal approach under anesthesia with pentobarbital sodium (Nembutal; Abbott Laboratories, North Chicago, IL, USA). Both the control and the OVX mice were killed under light ether anesthesia 4, 9, 18, 36, 72 and 108 days after operation and blood was collected from the trunk. All animal care procedures were carried out according to the USA NIH Guide for the Care and Use of Laboratory Animals [17] . Throughout the experiment, mice were kept in plastic cages (18 × 30 × 13 cm) with wood shavings, maintained in an animal room, which was air-conditioned (20-22 C and 60-70% relative humidity), artificially illuminated (14 h of light from 0500 h to 1900 h) and ventilated (16 times/h), and provided with commercial pellets (Lab MR-Breeder; Nihon Nosan Kogyo, Yokohama, Japan) and tap water ad libitum.
Serum PRL level
Blood collected was left at room temperature for 6 h, kept in a refrigerator overnight and centrifuged at 1,000 g for 20 min at 4 C. Serum was stored at 20 C. The PRL level was determined by a homologous radioimmunoassay [18] .
Normal and preneoplastic growth in the mammary gland
At autopsy, the right third thoracic mammary glands were prepared for the whole mount evaluation and were examined under the dissecting microscope at 10-fold magnification. The degree of end-bud formation was rated from 1 to 7 in increments of 1 [19] and the area bound by the tops of ducts was measured by a computerized digitizer (PIAS; Model LA-525, Tokyo, Japan) as an index of duct extension. The number and the area of preneoplastic mammary hyperplastic alveolar nodules (HAN) were also measured.
Dot blot analysis of TGFα and EGFR mRNA expression
At autopsy, bilateral inguinal and unilateral third thoracic mammary glands were immediately removed, pooled and stored at 70 C. RNA was extracted from 200-250 mg of frozen tissue by the acid guanidinium thiocyanate-phenol-chloroform extraction method [20] . The RNA concentration was determined by absorption at 260 nm. Each 20 µg of RNA from each sample was applied to a nylon membrane (Immobilon TM ; Millipore, Bedford, MA, USA) with a Bio-Dot manifold (Bio-Rad, Hercules, CA, USA) and then the RNA was fixed to the membrane by UV-crosslinking. The transforming growth factor α (TGFα) and epidermal growth factor receptor (EGFR) complementary DNA (cDNA) fluolescein-labelled probes were labelled with fluorescein using the Gene Images random prime labelling module kit (Amersham, Buckinghamshire, England). Dot blot analysis was performed by hybridization with these fluorescein-labelled cDNA probes for 16 h at 65 C. Signal was detected by using the Gene Images CDP-Star detection module kit (Amersham). The intensities of TGFα mRNA and EGFR mRNA were analyzed using a computer software, Multi-Analyst (BioRad).
The mouse TGFα and EGFR cDNA probes used were synthesized from the total RNA extracted from the mammary gland of the mouse by reverse transcriptase-polymerase chain reaction (RT-PCR). The PCR reaction for the probes of both TGFα and EGFR was performed for 40 cycles (94 C for 1 min, 55 C for 1 min, 72 C for 2 min) in a program temperature control system (Astec, Fukuoka, Japan). The sequence of the primers used for RT-PCR are shown in Table 1 [21] [22] [23] [24] . The other conditions were the same as detailed previously [25, 26] . In both assays, samples from all days were collected and dot blot analyses were done simultaneously. The data were expressed in terms of the percentage of the fluorecence intensity of the control at day 4.
Statistics
The statistical significance of differences between groups in each parameter was evaluated by Student's t-test.
Results
Mammary gland expression of TGFα and EGFR mRNAs
The expression of TGFα in the mammary gland was not significantly different between the control and the OVX groups on any day examined except for day 18 when the OVX group showed a significantly lower level of expression than its control. After day 18, TGFα mRNA showed a tendency of increase ( Fig. 1., Upper Panel) .
While the levels of expression of EGFR mRNA in the mammary gland were not significantly different among the controls, in different days, the levels of expression in the OVX groups were significantly lower than those in their respective controls after 18 days of OVX ( Fig. 1 ., Lower Pannel).
Normal and preneoplastic mammary gland growth
The mammary rating adopted as an index of endbud formation significantly decreased in the OVX groups compared to the control groups after 9 days of OVX. The mammary area remained the same in different groups indicating that the degree of duct extension was not changed after OVX (Fig. 2. , Upper Panels).
The number of HAN was significantly lower in the OVX group than in the control on days 9, 36, 72 and 108 after operation. No significant difference in the area of HAN was seen between the groups on any day (Fig. 2. , Lower Panels).
Serum PRL level
The serum PRL level tended to be lower in the OVX group than in the control after operation, although the difference was not statistically significant except for day 36 after operation ( Fig.  3) .
Discussion
In this study, we have observed that both endbuds and preneoplastic HAN in the mammary glands significantly regressed after OVX, which is a well-established phenomenon [27] . Associated with this, the decline in the circulating level of PRL, which is a key hormone for normal, preneoplastic and neoplastic growth of the mammary glands together with estrogen [15] , was observed as early as 4 days after OVX. Meanwhile, both TGFα and EGFR mRNAs declined significantly after 18 days of OVX, 9 days later than the commencement of mammary gland regression. Thereafter, TGFα mRNA tended to increase, while EGFR mRNA continued to decrease. Thus, the regression of normal and preneoplastic mammary gland after OVX may principally be ascribable to the lack or the decrease of the circulating level of estrogen or PRL, and the participation of EGFR in this process may be secondary at least under the present experimental conditions. Control, OVX. The data were expressed as Mean ± SEM. Number of samples examined was 6 in each group. a Number of HAN measured. ** Significantly smaller than the respective control at P<0.01.
